Abstract: The invention comprises a biomedically active/delivery site specific capsule-in-capsule liver supplement and method of use thereof. A first set of constituents, of an outer capsule, of a capsule-in-capsule liver supplement, comprises one or more of choline and phosphatidylcholine; a second set of constituents, of an inner capsule, comprise one or more of methionine, glycyrrhetinic acid, silymarin, and phosphatidylcholine; and either capsule optionally contains one or more liver aiding/regulating natural products, where the outer capsule dissolves in the stomach and the inner capsule dissolves in the small intestine. Thus, the dual dissolution process in controlled environments results in complementary and synergistic delivery of liver regulating molecules in a bioavailable form ready for transport through the wall of the small intestine.

Abstract: The invention comprises a biomedically active/delivery site specific capsule-in-capsule liver supplement and method of use thereof. A first set of constituents, of an outer capsule, of a capsule-in-capsule liver supplement, comprises one or more of choline and phosphatidylcholine; a second set of constituents, of an inner capsule, comprise one or more of methionine, glycyrrhetinic acid, silymarin, and phosphatidylcholine; and either capsule optionally contains one or more liver aiding/regulating natural products, where the outer capsule dissolves in the stomach and the inner capsule dissolves in the small intestine. Thus, the dual dissolution process in controlled environments results in complementary and synergistic delivery of liver regulating molecules in a bioavailable form ready for transport through the wall of the small intestine.

Abstract: Methods and systems for removing leukocytes from a biological fluid are disclosed. The methods and systems include a device that has a magnetic substrate coated with one or more polymeric materials that have an adhesion or adsorption affinity for leukocytes.

Abstract: Methods and systems for removing leukocytes from a biological fluid are disclosed. The methods and systems include a device that has a magnetic substrate coated with one or more polymeric materials that have an adhesion or adsorption affinity for leukocytes.

Abstract: The present invention provides a method for making sand compositions wherein manufactured sand particles are pretreated with a clay-mitigating polycation and blended with natural sand particles that have washed to remove fines such that at least 90% of the natural sand particles are retained on a 75 micron sieve. Methods of the invention also involve the use of the blended pretreated sand for making concrete wherein the sand is combined with cement, a polycarboxylate type dispersant, a further amount of clay-mitigating polycation compound, and at least one hydryoxyl or hydroxyl carboxylic acid or salt compound.

Abstract: The present invention provides a method for making sand compositions wherein manufactured sand particles are pretreated with a clay-mitigating polycation and blended with natural sand particles that have washed to remove fines such that at least 90% of the natural sand particles are retained on a 75 micron sieve. Methods of the invention also involve the use of the blended pretreated sand for making concrete wherein the sand is combined with cement, a polycarboxylate type dispersant, a further amount of clay-mitigating polycation compound, and at least one hydryoxyl or hydroxyl carboxylic acid or salt compound.

Abstract: The present invention includes a method and system of measuring alteration, alteration type, and alteration-causing species in process fluids and equipment and for controlling the process feeds and conditions to maximize the yields and equipment lifetime by minimizing the alteration. The invention includes an optical sensor comprising an optical fiber, a fiber grating written within the optical fiber, strain-tuned elements fixed to the optical fiber and an unaltered element, and an altered element fixed to the unaltered element.